Loading...
Jushi Holdings Inc.
JUSH.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.83
CA$0.05(6.41%)
Jushi Holdings Inc. (JUSH.CN) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Jushi Holdings Inc. (JUSH.CN), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
-29.19%
↓ 29.19%
Operating Income Growth
39.37%
↑ 39.37%
Net Income Growth
44.49%
↑ 44.49%
Operating Cash Flow Growth
581.64%
↑ 581.64%
Operating Margin
1.90%
↑ 1.90%
Gross Margin
43.67%
↑ 43.67%
Net Profit Margin
-18.54%
↓ 18.54%
ROE
106.07%
↑ 106.07%
ROIC
1.31%
↑ 1.31%
Jushi Holdings Inc. (JUSH.CN) Income Statement & Financial Overview
Review Jushi Holdings Inc. JUSH.CN income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $63.85M | $65.86M | $61.61M | $64.59M |
| Cost of Revenue | $38.07M | $40.45M | $33.61M | $32.03M |
| Gross Profit | $25.77M | $25.41M | $28.00M | $32.57M |
| Gross Profit Ratio | $0.40 | $0.39 | $0.45 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $33.16M | $54.50M | $32.23M | $27.82M |
| Operating Expenses | $27.65M | $27.25M | $27.82M | $24.16M |
| Total Costs & Expenses | $94.56M | $67.70M | $83.07M | $56.19M |
| Interest Income | $175049.00 | $78000.00 | $128000.00 | $337962.00 |
| Interest Expense | $10.12M | $9.51M | $9.51M | $12.75M |
| Depreciation & Amortization | $8.04M | $7.91M | $7.77M | $7.38M |
| EBITDA | $10.12M | $8.54M | $10.23M | $24.09M |
| EBITDA Ratio | $0.16 | $0.13 | $0.17 | $0.37 |
| Operating Income | -$1.87M | -$1.84M | $180000.00 | $8.40M |
| Operating Income Ratio | -$0.03 | -$0.03 | $0.003 | $0.13 |
| Other Income/Expenses (Net) | -$6.17M | -$7.04M | -$7.23M | -$1.01M |
| Income Before Tax | -$8.04M | -$8.88M | -$7.05M | $7.39M |
| Income Before Tax Ratio | -$0.13 | -$0.13 | -$0.11 | $0.11 |
| Income Tax Expense | $8.98M | $3.59M | $8.96M | $9.33M |
| Net Income | -$17.02M | -$12.47M | -$16.02M | -$1.94M |
| Net Income Ratio | -$0.27 | -$0.19 | -$0.26 | -$0.03 |
| EPS | -$0.09 | -$0.06 | -$0.08 | -$0.01 |
| Diluted EPS | -$0.09 | -$0.06 | -$0.08 | -$0.01 |
| Weighted Avg Shares Outstanding | $195.20M | $193.80M | $193.80M | $193.80M |
| Weighted Avg Shares Outstanding (Diluted) | $195.20M | $195.14M | $195.14M | $195.14M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan